Investing, Biotechnology, Venture Capital, Science, Immune System.
affibody binder called ZpA963. They made combinatorial libraries by randomizing key residues at the binding interface of this protein-protein complex. Through multiple rounds of coevolution selection, they were able to regenerate the original high-affinity ZpA963 complex, validating their approach